BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//HCP Ed-UK - ECPv6.15.14//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HCP Ed-UK
X-ORIGINAL-URL:https://hcp-ed.co.uk
X-WR-CALDESC:Events for HCP Ed-UK
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260312T124500
DTEND;TZID=UTC:20260312T140000
DTSTAMP:20260405T031632
CREATED:20260209T204837Z
LAST-MODIFIED:20260313T094806Z
UID:10001477-1773319500-1773324000@hcp-ed.co.uk
SUMMARY:SGLT2 Inhibitors: Beyond Glycaemic Control
DESCRIPTION:Beyond HbA1c: Modern Diabetes Care in Primary Care Nursing \n\n\n\nThe first in a series of three one-hour Lunch & Learn sessions designed for nurses working in general practice\, focusing on contemporary diabetes care beyond glycaemic control. \n\n\n\nSession 1 SGLT2 Inhibitors: Beyond Glycaemic Control \n\n\n\nSession overview/content:This session explores the role of SGLT2 inhibitors in modern diabetes care\, with a particularfocus on their cardiovascular and renal benefits. It will move beyond glucose lowering to helpnurses understand why these medications are increasingly used in people with type 2 diabeteswho have\, or are at risk of\, heart failure and chronic kidney disease. Practical nursingconsiderations\, monitoring\, and patient conversations will be highlighted throughout. \n\n\n\nAim:To enable primary care nurses to understand the non-glycaemic benefits of SGLT2 inhibitorsand their role in improving cardiovascular and renal outcomes in people with type 2 diabetes. \n\n\n\nLearning objectives: \n\n\n\n\nUnderstand key nursing considerations\, including side effects\, sick day rules\, and\n\n\n\npatient counselling\n\n\n\nBy the end of this session\, participants will be able to:\n\n\n\nDescribe how SGLT2 inhibitors work beyond glucose lowering\n\n\n\nExplain the cardiovascular benefits of SGLT2 inhibitors\, particularly in heart failure\n\n\n\nRecognise the renal protective effects of SGLT2 inhibitors in people with type 2\n\n\n\ndiabetes\n\n\n\nIdentify which patients in primary care are most likely to benefit from SGLT2 inhibitor\n\n\n\ntherapy\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\nSpeaker: Tracy Kirk – Director of Education at the Primary Care Respiratory Training Centre.
URL:https://hcp-ed.co.uk/event/sglt2-inhibitors-beyond-glycaemic-control/
LOCATION:Online Webinar
CATEGORIES:Diabetes,Live Presentation
ATTACH;FMTTYPE=image/png:https://hcp-ed.co.uk/wp-content/uploads/2026/02/SGLT2-Inhibitors-Beyond-Glycaemic-Control-1-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260319T083000
DTEND;TZID=UTC:20260319T163000
DTSTAMP:20260405T031632
CREATED:20260102T060154Z
LAST-MODIFIED:20260102T060201Z
UID:10001353-1773909000-1773937800@hcp-ed.co.uk
SUMMARY:North Wales Practice Nurse Spring Conference 2026
DESCRIPTION:This one-day conference is open to all Qualified Practice Nurses and ANPs working in or supporting Primary Care across North Wales. The event offers a valuable opportunity for regional practitioners to gather for education\, professional and personal development\, and networking. \n\n\n\nThe programme features a range of clinically relevant sessions delivered by expert speakers\, including: \n\n\n\n– Wound Care and Immunisation Updates \n\n\n\n– Dermatology and New Lipid Guidelines \n\n\n\n– Updates on Respiratory and Diabetes Care \n\n\n\n– Sexual Health \n\n\n\nIn addition to these sessions\, there will be opportunities to share best practice and experiences with your peers and colleagues. \n\n\n\nWe hope you will join us for what promises to be an engaging and informative event. Please book your free place now.
URL:https://hcp-ed.co.uk/event/north-wales-practice-nurse-spring-conference-2026/
LOCATION:Venue Cymru\, Penrhyn Crescent\, Llandudno\, LL30 1BB
CATEGORIES:Conference,Live Presentation
ATTACH;FMTTYPE=image/png:https://hcp-ed.co.uk/wp-content/uploads/2026/01/NWPN-Spring-Conf-2026-1.png
END:VEVENT
END:VCALENDAR